Explore Topics and Trends impacting today's markets

Even as the world was still grappling with effects of the pandemic a year after the virus first spawned shutdowns across the globe, considerable optimism started to take hold in early 2021 as countries began distributing COVID-19 vaccines. And at first, this translated into a strong economic rebound for parts of North America, Europe and Asia. But that soon would slow as new virus mutations and strains, coupled with roadblocks to mass vaccination, got in the way.

To be clear, people didn’t stop spending during the pandemic. As Blu Putnam and Erik Norland pointed out in an earlier episode of The Economists, many individuals simply shifted their spending from services to goods. So as economies began to reopen, the prevailing expectation was that pent-up demand for activities and services once again made available would cause consumers to throw their dollars in that direction.

This has happened to an extent, with spending on services greater now than it was during the 2020 shutdowns. But what we’re also seeing is that individuals continue to be highly selective as to how they spend their discretionary income. And it still remains to be seen if there will be enough of a shift from spending on goods to services to help ease some of the supply chain issues and upward price pressures of the past 18 months.

Even if consumer spending is not likely to fully revert to pre-pandemic patterns, Putnam says, “the good news is that there is enough progress and confidence [for the Fed] to commence an ever-so-slowly withdrawal of emergency support by reducing monthly asset purchases.” And that factors into the bottom line, which, according to Putnam, is that the economy is still improving.

Watch Putnam and Norland’s full discussion of consumer spending habits and the impact on the economy above.

The Economists is a video series covering the industries and events shaping global economics with a special focus on post-pandemic economic realities. Episodes are released monthly.


 

 

OpenMarkets is an online magazine and blog focused on global markets and economic trends. It combines feature articles, news briefs and videos with contributions from leaders in business, finance and economics in an interactive forum designed to foster conversation around the issues and ideas shaping our industry.

All examples are hypothetical interpretations of situations and are used for explanation purposes only. The views expressed in OpenMarkets articles reflect solely those of their respective authors and not necessarily those of CME Group or its affiliated institutions. OpenMarkets and the information herein should not be considered investment advice or the results of actual market experience. Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Swaps trading should only be undertaken by investors who are Eligible Contract Participants (ECPs) within the meaning of Section 1a(18) of the Commodity Exchange Act. Futures and swaps each are leveraged investments and, because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for either a futures or swaps position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles and only a portion of those funds should be devoted to any one trade because traders cannot expect to profit on every trade. BrokerTec Americas LLC (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (www.FINRA.org), and is a member of the Securities Investor Protection Corporation (www.SIPC.org). BAL does not provide services to private or retail customers.. In the United Kingdom, BrokerTec Europe Limited is authorised and regulated by the Financial Conduct Authority. CME Amsterdam B.V. is regulated in the Netherlands by the Dutch Authority for the Financial Markets (AFM) (www.AFM.nl). CME Investment Firm B.V. is also incorporated in the Netherlands and regulated by the Dutch Authority for the Financial Markets (AFM), as well as the Central Bank of the Netherlands (DNB).

©2024 CME Group Inc. All rights reserved